Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Endocrine 2Sarcoma 1Myeloid 1Lymphoid 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 4Myeloproliferative Disorders 3Blast Crisis 3Neoplasms 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Urologic Neoplasms 1Thyroid Neoplasms 1Thrombocytosis 1Soft Tissue Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pharyngeal Neoplasms 1Pancreatic Neoplasms 1Neurofibromatosis 2 1Neoplasms, Mesothelial 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1

Interventions

Cetuximab 2tipifarnib 1temsirolimus 1cc-486 1Valproic Acid 1Sirolimus 1Quality of Life 1Patient Reported Outcome Measures 1Panitumumab 1PLX8394 1Molecular Diagnostic Techniques 1Injections 1Immunotherapy 1Immunoglobulin G 1IFL protocol 1Gemcitabine 1Drug Therapy 1Disulfides 1Biological Therapy 1Bevacizumab 1Azacitidine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Bevacizumab × Myeloid × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡